TELA Bio, Inc. (TELA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US8723811084
TELA Bio, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 80.28 m USD |
| Gross profit | 54.34 m USD |
| Operating income | -33.76 m USD |
| EBIT | -33.36 m USD |
| Net income | -38.83 m USD |
| Diluted EPS – continuing operations | -0.83 USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About TELA Bio, Inc.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
More stocks
- Intellicheck, Inc. (IDN)
- SMCore.Inc (007820.KQ)
- Luminescence Technology Corp. (6729.TWO)
- BLUE BIOFUELS, INC. (BIOF)
- Dae Young Pkg (014160.KS)
- ELQ SA (ELQ.WA)
- Sunny Elec (004770.KS)
- Cliq Digital AG (CLIQ.SG)
- Serina Therapeutics, Inc. (SER)
- Sunny Pharmtech Inc. (6676.TWO)
- Tongyang Pile Inc (228340.KQ)
- MANHATTAN BRIDGE CAPITAL, INC (LOAN)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.